Where are the antivirals?

Today, Merck announced that it’s submitting an FDA application for a new antiviral that can be used against COVID19: molnupiravir. If approved, high risk people would take four capsules twice a day for five days early in their infection. This pill series cuts the risk of hospitalization or death in half. Two other antiviral pills (by Pfizer and Atea Pha…